Literature DB >> 4622185

Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.

W R McCabe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4622185

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  57 in total

1.  Humoral immunity to gram-negative bacillary infections in experimental animals and man.

Authors:  W R McCabe
Journal:  Infection       Date:  1975       Impact factor: 3.553

Review 2.  Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock.

Authors:  J D Baumgartner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

3.  Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.

Authors:  Catherine H Valentine; Judith Hellman; Laura K Beasley-Topliffe; Aranya Bagchi; H Shaw Warren
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

4.  Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.

Authors:  M Trautmann; H Hahn
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

5.  alpha-GlcNAc-1-->2-alpha-glc, the Salmonella homologue of a conserved lipopolysaccharide motif in the Enterobacteriaceae, elicits broadly cross-reactive antibodies.

Authors:  N A Nnalue
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 6.  Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients.

Authors:  A Cometta; J D Baumgartner; M P Glauser
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Reaginic antibody production to protein antigens of Escherichia coli and Pseudomonas aeruginosa by mice.

Authors:  P J Danneman; J G Michael
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

8.  Human antiserum for prevention of the local shwartzman reaction and death from bacterial lipopolysaccharides.

Authors:  E J Ziegler; H Douglas; A I Braude
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

9.  Lipid A and anti-lipid A.

Authors:  I Mattsby-Baltzer; B Kaijser
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.

Authors:  B W Fenwick; J S Cullor; B I Osburn; H J Olander
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.